Picture of Alimera Sciences logo

ALIM — Alimera Sciences News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapMomentum Trap

Alimera Sciences Inc reports results for the quarter ended in September - Earnings Summary

* Alimera Sciences Inc  ALIM.OQ  reported a quarterly adjusted
loss of 60 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 52 cents per share.
* Revenue fell 2.6% to $12.15 million from a year ago;  analysts
expected $12.37 million. 
* The mean earnings estimate of analysts had fallen by
about 101.9% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Alimera Sciences Inc shares had risen by 2.1% this quarter and
gained 2.1% so far this year.
* The company reported a quarterly loss of $4.18 million.
* Wall Street's median 12-month price target for Alimera
Sciences Inc is $14.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated October 28 at 01:33 p.m.
 ​All figures in US dollars unless otherwise stated

Recent news on Alimera Sciences

See all news